Invizyne Technologies Inc (IZTC)

May 08, 2025

Comparing Invizyne Technologies (NASDAQ:IZTC) and Caribou Biosciences (NASDAQ:CRBU) - Defense World

May 08, 2025

May 05, 2025

Invizyne Technologies Inc.’s (NASDAQ:IZTC) Lock-Up Period Set To Expire on May 12th - Defense World

May 05, 2025

May 04, 2025

Geode Capital Management LLC Makes New Investment in Invizyne Technologies Inc. (NASDAQ:IZTC) - Defense World

May 04, 2025

Apr 21, 2025

Bringing clarity and precision to the cell-free space by introducing exozymes - markets.businessinsider.com

Apr 21, 2025

Apr 20, 2025

Head-To-Head Contrast: iTeos Therapeutics (NASDAQ:ITOS) & Invizyne Technologies (NASDAQ:IZTC) - Defense World

Apr 20, 2025

Apr 11, 2025

EXoZymes Inc. Announces Its Latest Initiative BioClick - MarketScreener

Apr 11, 2025

Apr 11, 2025

Contrasting Invizyne Technologies (NASDAQ:IZTC) and C4 Therapeutics (NASDAQ:CCCC) - Defense World

Apr 11, 2025

Apr 02, 2025

EXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO - MarketScreener

Apr 02, 2025

Feb 22, 2025

EXoZymes, Inc. Announces Management Changes -February 21, 2025 at 04:37 pm EST - Marketscreener.com

Feb 22, 2025

Feb 22, 2025

ExoZymes Inc. appoints new board member and chairman By Investing.com - Investing.com Australia

Feb 22, 2025

Feb 21, 2025

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc. - The Manila Times

Feb 21, 2025

Feb 21, 2025

eXoZymes Inc. Announces Leadership Changes and Rebranding Following Transition from Invizyne Technologies - Nasdaq

Feb 21, 2025

Feb 19, 2025

EXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

Can This AI-Powered Enzyme Company Transform the Future of Biotech? Nasdaq's Newest IPO Makes Bold Claims - StockTitan

Feb 19, 2025

Feb 14, 2025

Positive week for Invizyne Technologies, Inc. (NASDAQ:EXOZ) institutional investors who control 42% of the company - Simply Wall St

Feb 14, 2025

Feb 13, 2025

Institutional investors own a significant stake of 42% in Invizyne Technologies, Inc. (NASDAQ:IZTC) - Yahoo Finance UK

Feb 13, 2025

Feb 13, 2025

Invizyne Technologies, Inc. will Change its Name to eXoZymes, Inc -February 12, 2025 at 12:00 am EST - Marketscreener.com

Feb 13, 2025

Feb 12, 2025

Invizyne Technologies, Inc. will Change its Ticker to EXOZ from IZTC -February 12, 2025 at 12:00 am EST - Marketscreener.com

Feb 12, 2025

Feb 12, 2025

What’s in a Name: Out with Invizyne, In with eXoZymes - Genetic Engineering & Biotechnology News

Feb 12, 2025

Feb 12, 2025

Rebranding Invizyne to eXoZymes Signifies a Sustainable - GlobeNewswire

Feb 12, 2025

Feb 12, 2025

Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging - EIN News

Feb 12, 2025

Feb 11, 2025

Invizyne Technologies rebrands as eXoZymes with new ticker EXOZ - MSN

Feb 11, 2025

Feb 10, 2025

Invizyne announces corporate name change to eXoZymes - MSN

Feb 10, 2025

Feb 10, 2025

Invizyne Technologies Announces Name Change To EXoZymes - Nasdaq

Feb 10, 2025

Feb 10, 2025

MDBHMDB Capital Holdings LLC-A Latest Stock News & Market Updates - StockTitan

Feb 10, 2025

Feb 10, 2025

Invizyne Technologies Changes Name to eXoZymes -February 10, 2025 at 11:31 am EST - Marketscreener.com

Feb 10, 2025

Feb 10, 2025

Invizyne Technologies rebrands as eXoZymes with new ticker EXOZ By Investing.com - Investing.com Nigeria

Feb 10, 2025

Feb 10, 2025

Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol - GlobeNewswire

Feb 10, 2025

Feb 10, 2025

Major Biotech Rebrand: Invizyne Becomes eXoZymesStrategic Move in Enzyme Manufacturing Space - Stock Titan

Feb 10, 2025

Jan 22, 2025

Invizyne technologies CEO Michael Heltzen buys $20,345 in stock - MSN

Jan 22, 2025

Jan 21, 2025

Invizyne technologies CEO Michael Heltzen buys $20,345 in stock By Investing.com - Investing.com Australia

Jan 21, 2025

Jan 11, 2025

Investors on Edge! What Invizyne’s Market Entry Means for Biotech’s Future - Jomfruland.net

Jan 11, 2025

Dec 16, 2024

Invizyne Technologies Inc.'s (NASDAQ:IZTC) Quiet Period To End on December 23rd - MarketBeat

Dec 16, 2024

Dec 16, 2024

Invizyne Technologies Inc.’s Quiet Period Set To Expire on December 23rd (NASDAQ:IZTC) - Defense World

Dec 16, 2024

Nov 25, 2024

Invizyne Technologies selected for $2 million project to advance SAF capabilities - Biomass Magazine

Nov 25, 2024

Nov 22, 2024

Invizyne Technologies Inc trading halted, volatility trading pause - TipRanks

Nov 22, 2024

Nov 22, 2024

Invizyne Technologies Inc trading resumes - Nasdaq

Nov 22, 2024

Nov 21, 2024

MDB Capital Holdings Provides Third Quarter 2024 Update - Marketscreener.com

Nov 21, 2024

Nov 21, 2024

Invizyne Technologies (IZTC) Income Statement & Balance Sheet 2024 - MarketBeat

Nov 21, 2024

Nov 21, 2024

MDB Capital Q3: Mayo Clinic Deal, AUM Surges to $28M, Invizyne IPO Success - StockTitan

Nov 21, 2024

Nov 20, 2024

Opening Day: Invizyne Technologies jumps after IPO - MSN

Nov 20, 2024

Nov 20, 2024

Invizyne technologies CEO acquires shares worth $22,022 By Investing.com - Investing.com Australia

Nov 20, 2024

Nov 19, 2024

Invizyne technologies CEO acquires shares worth $22,022 - Investing.com

Nov 19, 2024

Nov 19, 2024

Faculty in the News – James Bowie - UCLA – Chemistry and Biochemistry

Nov 19, 2024